LOGO IMAGE

서브상단이미지

Introduced Korea’s first stem cell breast augmentation in 2007

Over 6,000 related clinical trials for 15 years

Research and development of only stem cell medical technology

A leader in the development of stem cell
plastic medicine in Korea!

Beyond the popularization of stem cell breast augmentation, stem cell facioplasty, and stem cell female surgery, stem cell anti-aging treatment (anti-aging), stem cell pain treatment such as waist and knee joints. Development of Korean stem cell advanced medical treatment, including establishment of stem Cell Banking

75% of engraftment rate proven in 4 international papers

A proven hospital that can give you confidence by just a single visit

Submission of international thesis with the result of engraftment rate averaged from thousands of clinical results

The only hospital in Korea that has proven that the adipocyte engraftment rate of stem cell breast augmentation reached an average of
75% over 4 times in 2010, 2012, 2015 and 2020.

In 2020, the world's leading academic journal, Oxford thesis,
Proven as the ONLY technology to achieve OVER 75% stem cell engraftment rate by the world’s leading academic journal “Oxford Thesis”

The Oxford Journal (OXFORD AESTHETIC SURGERY JOURNAL OPEN FORUM) proved
the accurate stem cell surgery method through actual clinical cases and the figure that the engraftment rate after
stem cell mammoplasty may reach 75%.

TGI, cell counter, 3D scatter, top secret stem cell extraction

Establishment of Korea's best stem cell medical environment

Developed the best stem cell extraction equipment beyond TGI Heuricell by developing, experiencing, and studying
all stem cell related equipment for 15 years and cultivating big data. Established the Korea's best stem cell medical environment
with the most advanced specialized equipment such as precision cell counter, 3D scanner that predicts the amount of transplantation, and hyperbaric oxygen treatment equipment.

Representative director Shin Dong-jin was recognized for his contribution to the development of stem cell plastic medicine through 11 awards for 13 years, including the Minister of Health and Welfare Award in 2014 and the Minister of Food and Drug Safety Award twice in 2015 and 2016.
Continuous research on new stem cell-related medical technologies after the establishment of a dedicated stem cell research and development department accredited by the Ministry of Science and ICT in 2017